Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia.
Caocci
G
G
Atzeni
S
S
Orrù
N
N
Azzena
L
L
Martorana
L
L
Littera
R
R
Ledda
A
A
La Nasa
G
G
D000368:Aged; D000069439:Dasatinib; D006177:Gynecomastia / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use; D016896:Treatment Outcome
D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D020845:Selective Estrogen Receptor Modulators; D013844:Thiazoles; D013629:Tamoxifen; D000069439:Dasatinib